249 related articles for article (PubMed ID: 12904965)
1. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.
Chagraoui A; Protais P; Filloux T; Mocaër E
Psychopharmacology (Berl); 2003 Oct; 170(1):17-22. PubMed ID: 12904965
[TBL] [Abstract][Full Text] [Related]
2. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.
Millan MJ; Gobert A; Lejeune F; Dekeyne A; Newman-Tancredi A; Pasteau V; Rivet JM; Cussac D
J Pharmacol Exp Ther; 2003 Sep; 306(3):954-64. PubMed ID: 12750432
[TBL] [Abstract][Full Text] [Related]
3. Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
Norman TR; Cranston I; Irons JA; Gabriel C; Dekeyne A; Millan MJ; Mocaër E
Eur J Pharmacol; 2012 Jan; 674(1):27-32. PubMed ID: 22040921
[TBL] [Abstract][Full Text] [Related]
4. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
Millan MJ; Brocco M; Gobert A; Dekeyne A
Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999
[TBL] [Abstract][Full Text] [Related]
6. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
Dekeyne A; Mannoury la Cour C; Gobert A; Brocco M; Lejeune F; Serres F; Sharp T; Daszuta A; Soumier A; Papp M; Rivet JM; Flik G; Cremers TI; Muller O; Lavielle G; Millan MJ
Psychopharmacology (Berl); 2008 Sep; 199(4):549-68. PubMed ID: 18523738
[TBL] [Abstract][Full Text] [Related]
7. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
Millan MJ; Marin P; Kamal M; Jockers R; Chanrion B; Labasque M; Bockaert J; Mannoury la Cour C
Int J Neuropsychopharmacol; 2011 Jul; 14(6):768-83. PubMed ID: 20946699
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
Millan MJ; Peglion JL; Lavielle G; Perrin-Monneyron S
Eur J Pharmacol; 1997 Apr; 325(1):9-12. PubMed ID: 9151932
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.
Bourin M; Mocaër E; Porsolt R
J Psychiatry Neurosci; 2004 Mar; 29(2):126-33. PubMed ID: 15069466
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.
Bertaina-Anglade V; la Rochelle CD; Boyer PA; Mocaër E
Behav Pharmacol; 2006 Dec; 17(8):703-13. PubMed ID: 17110796
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.
Soumier A; Banasr M; Lortet S; Masmejean F; Bernard N; Kerkerian-Le-Goff L; Gabriel C; Millan MJ; Mocaer E; Daszuta A
Neuropsychopharmacology; 2009 Oct; 34(11):2390-403. PubMed ID: 19571795
[TBL] [Abstract][Full Text] [Related]
12. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
13. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
Kimura Y; Hatanaka K; Naitou Y; Maeno K; Shimada I; Koakutsu A; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2004 Jan; 483(1):37-43. PubMed ID: 14709324
[TBL] [Abstract][Full Text] [Related]
15. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
[TBL] [Abstract][Full Text] [Related]
16. Agomelatine affects rat suprachiasmatic nucleus neurons via melatonin and serotonin receptors.
Yang J; Jin HJ; Mocaër E; Seguin L; Zhao H; Rusak B
Life Sci; 2016 Jun; 155():147-54. PubMed ID: 27269050
[TBL] [Abstract][Full Text] [Related]
17. Synergistic actions of apomorphine and m-chlorophenylpiperazine on ejaculation, but not penile erection in rats.
Yonezawa A; Yoshizumi M; Ise SN; Watanabe C; Mizoguchi H; Furukawa K; Tsuru H; Kimura Y; Kawatani M; Sakurada S
Biomed Res; 2009 Apr; 30(2):71-8. PubMed ID: 19420729
[TBL] [Abstract][Full Text] [Related]
18. Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.
Protais P; Windsor M; Mocaër E; Comoy E
Psychopharmacology (Berl); 1995 Aug; 120(4):376-83. PubMed ID: 8539317
[TBL] [Abstract][Full Text] [Related]
19. Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons.
Chenu F; Shim S; El Mansari M; Blier P
J Psychopharmacol; 2014 Feb; 28(2):162-7. PubMed ID: 24189440
[TBL] [Abstract][Full Text] [Related]
20. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
